Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolia in Acute Charcot Neuroarthropathy
NCT03174366Phase 3Completed
- Sponsor
- Western University of Health Sciences
- Start
- May 2017
- Primary completion
- Jun 2018
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab in Charcot neuroarthropathy (CN), sponsored by Western University of Health Sciences. Started May 2017; status: completed.
02
Drugs
denosumab
03
Conditions
Charcot neuroarthropathy (CN)
Beyond the preview
Go deeper on NCT03174366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03174366.